Capstan Therapeutics
David Diamond, Ph.D., is Capstan’s Vice President of Intellectual Property. David has more than 20 years of intellectual property (IP) experience in the life sciences industry. Prior to Capstan, he served as a patent agent at K&L Gates, where he wrote and prosecuted patents and conducted patent landscape, portfolio and patentability analyses for his clients. David previously spent 16 years in increasing roles of responsibility heading the IP sector at MannKind Corporation.
This person is not in any offices
Capstan Therapeutics
2 followers
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.